Table 2.
Relationships between clinical outcomes and recovery at 90 days and baseline biological concentrations in plasma
| IGF‐1 | IGFBP‐3 | cGP | cGP/IGF‐1 ratio | ||
|---|---|---|---|---|---|
| NIHSS (n = 28) | B | 0.006 | 0.00 | −0.06 | −0.30 |
| P | 0.11 | 0.09 | 0.36 | 0 .03 | |
| 95%CI | (−0.002, 0.01) | (0, 0.001) | (−0.21, 0.08) | (−0.59, −0.02) | |
| mRS (n = 28) | B | −0.001 | 0.00 | 0.09 | 0.19 |
| P | 0.72 | 0.52 | 0.10 | 0.08 | |
| 95%CI | (−0.008, 0.005) | (−0.001, 0) | (−0.02, 0.20) | (−0.03, 0.42) | |
| FM (n = 27) | B | −0.01 | −0.002 | 0.84 | 2.33 |
| p | 0.64 | 0.38 | 0.16 | 0.05 | |
| 95%CI | (−0.08, 0.05) | (−0.007, 0.003) | (−0.35, 2.04) | (−0.07, 4.73) | |
| ∆NIHSS (n = 28) | B | −0.006 | 0.00 | 0.06 | 0.30 |
| P | 0.11 | 0.09 | 0.36 | 0.03 | |
| 95%CI | (−0.01,0.002) | (−0.001,0.00) | (−0.08, 0.21) | (0.02,0.59) | |
NIHSS, the National Institutes of Health Stroke Scale; ∆NIHSS, the change between baseline and 90 days in the National Institutes of Health Stroke Scale; mRS, the modified Rankin Scale score; FM, The Fugl‐Meyer Upper Limb Assessment Scale score; B, beta coefficients; 95%CI, 95% confidence intervals. The analysis was adjusted for age and baseline NIHSS.